Log In
Print
BCIQ
Print
Print this Print this
 

romosozumab (AMG 785, CDP7851)

Also known as: anti-sclerostin antibody

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionHumanized mAb against sclerostin
Molecular Target Sclerostin
Mechanism of ActionBinds sclerostin
Latest Stage of DevelopmentPhase III
IndicationOsteoporosis
Partner

UCB Group
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today